Differentiation between invasive ductal carcinoma and ductal carcinoma in situ by combining intratumoral and peritumoral ultrasound radiomics

被引:0
|
作者
Zhang, Heng [1 ,2 ,3 ,4 ]
Zhao, Tong [5 ]
Ding, Jiangyi [1 ,2 ,3 ,4 ]
Wang, Ziyi [1 ,2 ,3 ,4 ]
Cao, Nannan [1 ,2 ,3 ,4 ]
Zhang, Sai [1 ,2 ,3 ,4 ]
Xie, Kai [1 ,2 ,3 ,4 ]
Sun, Jiawei [1 ,2 ,3 ,4 ]
Gao, Liugang [1 ,2 ,3 ,4 ]
Li, Xiaoqin [5 ]
Ni, Xinye [1 ,2 ,3 ,4 ]
机构
[1] Nanjing Med Univ, Changzhou 2 Peoples Hosp, Dept Radiotherapy Oncol, Changzhou, Peoples R China
[2] Jiangsu Prov Engn Res Ctr Med Phys, Changzhou, Peoples R China
[3] Nanjing Med Univ, Med Phys Res Ctr, Changzhou, Peoples R China
[4] Key Lab Med Phys Changzhou, Changzhou, Peoples R China
[5] Nanjing Med Univ, Changzhou 2 Peoples Hosp, Dept Ultrasound, Changzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Radiomics; Ultrasound; Breast cancer; Peritumoral features; BREAST; CANCER; FEATURES;
D O I
10.1186/s12938-024-01315-y
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
BackgroundThis study aimed to develop and validate an ultrasound radiomics model for distinguishing invasive ductal carcinoma (IDC) from ductal carcinoma in situ (DCIS) by combining intratumoral and peritumoral features.MethodsRetrospective analysis was performed on 454 patients from Chengzhong Hospital. The patients were randomly divided in accordance with a ratio of 8:2 into a training group (363 cases) and validation group (91 cases). In addition, 175 patients from Yanghu Hospital were used as the external test group. The peritumoral ranges were set to 2, 4, 6, 8, and 10 mm. Mann-Whitney U-test, recursive feature elimination, and a least absolute shrinkage and selection operator were used to in the dimension reduction of the radiomics features and clinical knowledge, and machine learning logistic regression classifiers were utilized to construct the diagnostic model. The area under the curve (AUC) of the receiver operating characteristics, accuracy, sensitivity, and specificity were used to evaluate the model performance.ResultsBy combining peritumoral features of different ranges, the AUC of the radiomics model was improved in the validation and test groups. In the validation group, the maximum increase in AUC was 9.7% (P = 0.031, AUC = 0.803) when the peritumoral range was 8 mm. Similarly, when the peritumoral range was only 8 mm in the test group, the maximum increase in AUC was 4.9% (P = 0.005, AUC = 0.770). In this study, the best prediction performance was achieved when the peritumoral range was only 8 mm.ConclusionsThe ultrasound-based radiomics model that combined intratumoral and peritumoral features exhibits good ability to distinguish between IDC and DCIS. The selection of peritumoral range size exerts an important effect on the prediction performance of the radiomics model.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Ductal Carcinoma In Situ
    Bychkovsky, Brittany L.
    Myers, Sara
    Warren, Laura E. G.
    De Placido, Pietro
    Parsons, Heather A.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2024, 38 (04) : 831 - 849
  • [42] Epidemiology of Ductal Carcinoma In Situ
    Iatrakis, Georgios
    Zervoudis, Stefanos
    CHIRURGIA, 2021, 116 (05) : S15 - S21
  • [43] Ductal carcinoma in situ
    Tulusan A.H.
    Bühner M.
    Parchent H.
    Rinas N.
    Kastner P.
    Der Gynäkologe, 2005, 38 (1): : 65 - 74
  • [44] Ductal Carcinoma In Situ
    Fu, FangMeng
    Gilmore, Richard C.
    Jacobs, Lisa K.
    SURGICAL CLINICS OF NORTH AMERICA, 2018, 98 (04) : 725 - +
  • [45] Loss of heterozygosity analyses of asynchronous lesions of ductal carcinoma in situ and invasive ductal carcinoma of the human breast
    Amari, M
    Moriya, T
    Ishida, T
    Harada, Y
    Ohnuki, K
    Takeda, M
    Sasano, H
    Horii, A
    Ohuchi, N
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2003, 33 (11) : 556 - 562
  • [46] Insights into the transition of ductal carcinoma in situ to invasive ductal carcinoma: morphology, molecular portraits, and the tumor microenvironment
    Chen, Weiling
    Wang, Guimei
    Zhang, Guojun
    CANCER BIOLOGY & MEDICINE, 2022, 19 (10) : 1487 - 1495
  • [47] Exploring Ductal Carcinoma In-Situ to Invasive Ductal Carcinoma Transitions Using Energy Minimization Principles
    Sheraton, Vivek M.
    Ma, Shijun
    COMPUTATIONAL SCIENCE - ICCS 2022, PT I, 2022, : 375 - 388
  • [48] The Effect of Smoking on Progression from Ductal Carcinoma In Situ to Invasive Ductal Breast Carcinoma: A Retrospective Study
    Takada, Koji
    Kashiwagi, Shinichiro
    Asano, Yuka
    Goto, Wataru
    Morisaki, Tamami
    Shibutani, Masatsune
    Tanaka, Hiroaki
    Hirakawa, Kosei
    Ohira, Masaichi
    ANTICANCER RESEARCH, 2022, 42 (01) : 311 - 320
  • [49] CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions
    Barth, PJ
    Ebrahimsade, S
    Ramaswamy, A
    Moll, R
    VIRCHOWS ARCHIV, 2002, 440 (03) : 298 - 303
  • [50] Identifying ductal carcinoma in situ cases not requiring surgery to exclude postoperative upgrade to invasive ductal carcinoma
    Nakayama, Sayuka
    Masuda, Hiroko
    Miura, Sakiko
    Kuwayama, Takashi
    Hashimoto, Rikako
    Taruno, Kanae
    Sawada, Terumasa
    Akashi-Tanaka, Sadako
    Nakamura, Seigo
    BREAST CANCER, 2022, 29 (04) : 610 - 617